BSE filing, NSE: ARMANFIN. Summary written from the filing by ALFA Finder's alert engine.
Arman Financial Services Ltd: key numbers
- Share price
- ₹1,390.80
- Market cap
- ₹1,467 Cr
- Revenue (annual)
- ₹645.9 Cr
- Net profit (annual)
- ₹56.61 Cr
- P/E (TTM)
- 12.6×Sector 19.7×
- Promoter holding
- 21.93%-0.07% QoQ
- FII holding
- 2.85%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Arman Financial Services Ltd
All →Arman Financial Services Debt & Borrowing: ₹3.58 Cr
Arman Financial Services paid quarterly interest of ₹3.58 Crore on its ₹125 Crore NCD issue. The Reg 57 certificate confirms timely debt-service fulfilment.
- Value
- ₹3.58 Cr
Arman Financial Services Board Meeting Date
Arman Financial Services scheduled a board meeting for November 4, 2026 to consider unaudited quarterly and half-year results. The trading window for designated persons remains closed until 48 hours after the results are declared.
Arman Financial Services Credit Rating
CARE Ratings reaffirmed Arman Financial's 'CARE A-' rating on its NCDs and revised the outlook from Negative to Stable, covering its subsidiary Namra Finance too. The rated facilities total ₹42.00 crore plus a proposed ₹28.89 crore NCD issue.
Arman Financial Services Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ending September 30, 2026.
Arman Financial Services Management Change
Arman Financial Services Limited appointed Mr. Chandramouli Akkiraju as Chief Business Officer of its wholly owned subsidiary, Namra Finance Limited, effective October 16, 2026.
Arman Financial Services Promoter Selling
Promoter Himani Manakiwala sold 500 Arman Financial Services shares in the open market. The reduction trimmed his stake from 4,834 to 4,334 shares.
- Promoter stake change
- -0.01%
Other board meeting date announcements
All →Natco Pharma Board Meeting Date
Natco Pharma will hold a board meeting on 13 November 2026 to consider unaudited quarterly results and an interim dividend. Trading window closed until 15 November 2026.
Faze Three Board Meeting Date
Faze Three Ltd intimated a board meeting on November 3, 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closure is also noted.
Real Eco-Energy Board Meeting Date
Real Eco-Energy schedules a board meeting on 04 November 2026 for unaudited quarterly results. The trading window stays closed until results are declared.
Arvaya Healthcare Board Meeting Date
Arvaya Healthcare schedules a 4 November 2026 board meeting on rights issue, draft letter of offer and related party transactions. Agenda items remain proposed only.
Prism Johnson Board Meeting Date
Prism Johnson intimated a board meeting on 6 November 2026 to consider unaudited standalone and consolidated results for the quarter and half year ended September 2026. The meeting has not yet been held.
Bharat Textiles & Proofing Industries Board Meeting Date
Bharat Textiles & Proofing Industries will hold a board meeting on 05 November 2026 to consider unaudited standalone quarterly and half-year results. Results await approval.